X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES NATCO PHARMA JUBILANT LIFE SCIENCES/
NATCO PHARMA
 
P/E (TTM) x 20.1 33.8 59.3% View Chart
P/BV x 4.3 17.2 24.8% View Chart
Dividend Yield % 0.4 0.7 64.1%  

Financials

 JUBILANT LIFE SCIENCES   NATCO PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
NATCO PHARMA
Mar-14
JUBILANT LIFE SCIENCES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs187877 21.3%   
Low Rs65424 15.4%   
Sales per share (Unadj.) Rs364.3223.4 163.1%  
Earnings per share (Unadj.) Rs6.831.1 22.0%  
Cash flow per share (Unadj.) Rs24.540.3 60.8%  
Dividends per share (Unadj.) Rs3.005.00 60.0%  
Dividend yield (eoy) %2.40.8 309.8%  
Book value per share (Unadj.) Rs164.9219.5 75.1%  
Shares outstanding (eoy) m159.2833.07 481.6%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x0.32.9 11.9%   
Avg P/E ratio x18.420.9 87.9%  
P/CF ratio (eoy) x5.116.1 31.8%  
Price / Book Value ratio x0.83.0 25.8%  
Dividend payout %43.816.1 272.3%   
Avg Mkt Cap Rs m20,06121,504 93.3%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0521,128 980.0%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,0347,389 785.4%  
Other income Rs m191167 114.1%   
Total revenues Rs m58,2247,556 770.6%   
Gross profit Rs m5,7861,793 322.7%  
Depreciation Rs m2,812304 923.7%   
Interest Rs m3,237366 884.0%   
Profit before tax Rs m-721,290 -5.6%   
Minority Interest Rs m-28646 -617.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696309 225.6%   
Profit after tax Rs m1,0901,027 106.1%  
Gross profit margin %10.024.3 41.1%  
Effective tax rate %-965.923.9 -4,035.6%   
Net profit margin %1.913.9 13.5%  
BALANCE SHEET DATA
Current assets Rs m29,2803,681 795.4%   
Current liabilities Rs m38,9123,123 1,246.0%   
Net working cap to sales %-16.67.6 -219.5%  
Current ratio x0.81.2 63.8%  
Inventory Days Days8489 94.3%  
Debtors Days Days5159 86.4%  
Net fixed assets Rs m55,7127,685 724.9%   
Share capital Rs m155331 46.7%   
"Free" reserves Rs m20,9686,670 314.4%   
Net worth Rs m26,2657,259 361.8%   
Long term debt Rs m17,169955 1,798.0%   
Total assets Rs m88,60611,957 741.0%  
Interest coverage x1.04.5 21.6%   
Debt to equity ratio x0.70.1 496.9%  
Sales to assets ratio x0.70.6 106.0%   
Return on assets %4.911.7 41.9%  
Return on equity %4.214.2 29.3%  
Return on capital %11.620.7 55.8%  
Exports to sales %37.839.4 96.0%   
Imports to sales %16.55.7 289.2%   
Exports (fob) Rs m21,9332,908 754.3%   
Imports (cif) Rs m9,567421 2,271.4%   
Fx inflow Rs m22,0043,445 638.7%   
Fx outflow Rs m11,749703 1,671.7%   
Net fx Rs m10,2552,743 373.9%   
CASH FLOW
From Operations Rs m8,0261,440 557.3%  
From Investments Rs m-1,744-1,089 160.1%  
From Financial Activity Rs m-4,447-353 1,261.0%  
Net Cashflow Rs m1,834-1 -123,117.4%  

Share Holding

Indian Promoters % 45.6 52.0 87.6%  
Foreign collaborators % 3.5 1.5 238.1%  
Indian inst/Mut Fund % 8.7 7.8 111.0%  
FIIs % 21.2 16.6 127.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 26.0 81.2%  
Shareholders   23,815 25,395 93.8%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 18, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS